AFFILIATIONS
1 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
2 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
3 Department of Hematology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
4 Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
5 Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan, China
6 Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
7 Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
8 Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
9 Hematology Institute of Hebei Province, Second Hospital of Hebei Medical University, Shijiazhuang, China
10 Department of Medical Laboratory, First Affiliated Hospital of Nanchang University, Nanchang, China
11 Department of Obstetrics and Gynecology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
12 Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China
13 Department of Hematology, the Second Affiliated Hospital of Xiamen Medical College, Xiamen, China
14 Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, Guangxi, China
15 Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan, China
16 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
17 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
18 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
19 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
20 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
21 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
22 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
23 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
24 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
25 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China
26 1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China 2. National Clinical Research Center for Hematologic Disease, Beijing, China 3. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; 4. Collaborative Innovation Center of Hematology, Peking University Institute of Hematology, Beijing, China, Beijing, China